Anja Lorch

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

Klaus‐Peter Dieckmann, Arlo Radtke, Lajos Géczi et al. · Journal of Clinical Oncology · 2019 · 330 citations · Full text

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

J. Beyer, Peter Albers, Renske Altena et al. · Annals of Oncology · 2012 · 320 citations · Full text

ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

Friedemann Honecker, Jorge Aparicio, Daniel M. Berney et al. · Annals of Oncology · 2018 · 319 citations · Full text

Conventional-Dose Versus High-Dose Chemotherapy As First Salvage Treatment in Male Patients With Metastatic Germ Cell Tumors: Evidence From a Large International Database

Anja Lorch, Caroline Mollévi, Andrew Kramar et al. · Journal of Clinical Oncology · 2011 · 263 citations · Full text